+91 789 2456 581 | info@nckpharma.com

Pharma News

Keep updating your pharma knowledge
18 May 2018

“A Phase 3 trial is randomized, double-blind, and placebo-controlled” – What it signifies?

“A Phase 3 trial is randomized, double-blind, and placebo-controlled” – What it signifies?

We sometime confuse the terminologies of clinical trial and whenever you come across certain clinical trial – you will look into the clinical trial design. Here as it mentioned particular trial is randomized, double-blind, and placebo-controlled. If you break down and analyse each component, then clinical trial design methodology will be understanding.

  • Randomized: Each study subject is randomly assigned to receive either the study treatment or a placebo.
  • Blind: The subjects involved in the study do not know which study treatment they receive. If the study is double-blind, the researchers also do not know which treatment a subject receives. This intent is to prevent researchers from treating the two groups differently. A form of double-blind study called a “double-dummy” design allows additional insurance against bias. In this kind of study, all patients are given both placebo and active doses in alternating periods.
  • Placebo-controlled: The use of a placebo allows the researchers to isolate the effect of the study treatment from the placebo effect.

What is placebo effect? >> Read Now

Leave a Reply

Scale up your Pharma knwledge to Next Level with our Free Content

Case studies & Caselets
Simulation based learning
Online self competency assessment tests 

etc.